308 related articles for article (PubMed ID: 38310228)
1. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.
Zheng H; Liu Y; Deng Y; Li Y; Liu S; Yang Y; Qiu Y; Li B; Sheng W; Liu J; Peng C; Wang W; Yu H
Mol Med; 2024 Feb; 30(1):20. PubMed ID: 38310228
[TBL] [Abstract][Full Text] [Related]
2. HSP90 Exacerbates Bone Destruction in Rheumatoid Arthritis by Activating TRAF6/NFATc1 Signaling.
Wang Q; Kong X; Guo W; Liu L; Tian Y; Tao X; Lin N; Su X
Inflammation; 2024 Feb; 47(1):363-375. PubMed ID: 37902841
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Peroxisome Proliferator-Activated Receptor γ Coactivator 1β/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis.
Ma JD; Jing J; Wang JW; Mo YQ; Li QH; Lin JZ; Chen LF; Shao L; Miossec P; Dai L
Arthritis Rheumatol; 2019 Aug; 71(8):1252-1264. PubMed ID: 30802366
[TBL] [Abstract][Full Text] [Related]
6. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways.
Wei ZF; Tong B; Xia YF; Lu Q; Chou GX; Wang ZT; Dai Y
PLoS One; 2013; 8(3):e59171. PubMed ID: 23536866
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K
Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1.
Yamashita T; Yao Z; Li F; Zhang Q; Badell IR; Schwarz EM; Takeshita S; Wagner EF; Noda M; Matsuo K; Xing L; Boyce BF
J Biol Chem; 2007 Jun; 282(25):18245-18253. PubMed ID: 17485464
[TBL] [Abstract][Full Text] [Related]
9. Ethyl Acetate Fraction of Aqueous Extract of Lentinula edodes Inhibits Osteoclastogenesis by Suppressing NFATc1 Expression.
Lee H; Lee K; Lee S; Lee J; Jeong WT; Lim HB; Hyun TK; Yi SJ; Kim K
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32079267
[TBL] [Abstract][Full Text] [Related]
10. IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).
Chen Z; Su L; Xu Q; Katz J; Michalek SM; Fan M; Feng X; Zhang P
J Biol Chem; 2015 Dec; 290(50):30163-74. PubMed ID: 26483549
[TBL] [Abstract][Full Text] [Related]
11. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
Tsuji-Naito K
Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 26 suppresses receptor activator of nuclear factor κB ligand induced osteoclastogenesis via down-regulation of nuclear factor of activated T-cells, cytoplasmic 1 and nuclear factor κB activity.
Peng YJ; Wang CY; Lin YH; Lin GJ; Huang SH; Shyu JF; Sytwu HK; Cheng CP
Rheumatology (Oxford); 2016 Nov; 55(11):2074-2083. PubMed ID: 27550297
[TBL] [Abstract][Full Text] [Related]
13. Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in rats.
Li YJ; Kukita A; Watanabe T; Takano T; Qu P; Sanematsu K; Ninomiya Y; Kukita T
Lab Invest; 2012 Dec; 92(12):1777-87. PubMed ID: 23044922
[TBL] [Abstract][Full Text] [Related]
14. TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB.
Zhang P; Liu J; Xu Q; Harber G; Feng X; Michalek SM; Katz J
J Biol Chem; 2011 Jul; 286(27):24159-69. PubMed ID: 21566133
[TBL] [Abstract][Full Text] [Related]
15. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
16. Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCγ1-Ca
Zeng X; Zhang Y; Wang S; Wang K; Tao L; Zou M; Chen N; Xu J; Liu S; Li X
Biochem Pharmacol; 2017 Jan; 124():57-68. PubMed ID: 27789216
[TBL] [Abstract][Full Text] [Related]
17. TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression.
Tokunaga T; Mokuda S; Kohno H; Yukawa K; Kuranobu T; Oi K; Yoshida Y; Hirata S; Sugiyama E
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991837
[TBL] [Abstract][Full Text] [Related]
18. Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption.
Inoue K; Hu X; Zhao B
FASEB J; 2020 Feb; 34(2):2392-2407. PubMed ID: 31908034
[TBL] [Abstract][Full Text] [Related]
19. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
[TBL] [Abstract][Full Text] [Related]
20. The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.
Kogawa M; Hisatake K; Atkins GJ; Findlay DM; Enoki Y; Sato T; Gray PC; Kanesaki-Yatsuka Y; Anderson PH; Wada S; Kato N; Fukuda A; Katayama S; Tsujimoto M; Yoda T; Suda T; Okazaki Y; Matsumoto M
J Biol Chem; 2013 Oct; 288(43):31299-312. PubMed ID: 23990468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]